{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEGL-21019 Advising on and issuing PEPSE in under 13 year olds guideline 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "GUIDELINE FOR ADVISING ON AND ISSUING HIV PEPSE IN CHILDREN AGED UNDER 13 YEARS OLD"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEGL-21019"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All Clinicians assessing need for HIV PEPSE in children aged under 13 years"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "25 August 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "24 August 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "Children, PEPSE, HIV drugs, anti- retrovirals"
                    },
                    {
                        "text": "Developed in response to: (National Guidance/Recommendations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "SARC Request"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division"
                    },
                    {
                        "text": "Division 7"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Laura Hilton"
                    },
                    {
                        "text": "HIV Nurse Consultant"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "< 13 PEPSE working group HIV Clinical Governance group"
                    },
                    {
                        "text": "05 July 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dr Mandeep Singh"
                    },
                    {
                        "text": "Medical Director, Women's and Children Division"
                    },
                    {
                        "text": "16 August 2021"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "24 August 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "September 2021"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEGL-21019 Advising on and issuing PEPSE in under 13 year olds guideline 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 8,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Sarah Thompson"
                    },
                    {
                        "text": "Specialist HIV Pharmacist"
                    },
                    {
                        "text": "20 July 2021"
                    },
                    {
                        "text": "Dr Thilani Ranasinghe"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "27 April 2021"
                    },
                    {
                        "text": "Dr Aparajita Ganguly"
                    },
                    {
                        "text": "Paediatric Registrar"
                    },
                    {
                        "text": "26 April 2021"
                    },
                    {
                        "text": "Dr Deepika Katangodage"
                    },
                    {
                        "text": "Paediatric associate Specialist"
                    },
                    {
                        "text": "27 April 2021"
                    },
                    {
                        "text": "Bev McMahon"
                    },
                    {
                        "text": "Acting Associate Director \u2013 Women and Children's directorate"
                    },
                    {
                        "text": "05 July 2021"
                    },
                    {
                        "text": "Viv Kemp"
                    },
                    {
                        "text": "SARC Manager"
                    },
                    {
                        "text": "26 May 2021"
                    },
                    {
                        "text": "Dr Kate Shardlow"
                    },
                    {
                        "text": "SARC Medical Director"
                    },
                    {
                        "text": "26 May 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Group if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "HIV Clinical Governance Group"
                    },
                    {
                        "text": "05 July 2021"
                    },
                    {
                        "text": "Medication Assurance Group"
                    },
                    {
                        "text": "20 July 2021"
                    },
                    {
                        "text": "Accident Centre Director"
                    },
                    {
                        "text": "01 July 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust documents (to be read in conjunction with)"
                    },
                    {
                        "text": "None"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Laura Hilton"
                    },
                    {
                        "text": "Newly created MSE guideline. No previous guideline in place."
                    },
                    {
                        "text": "25 August 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role and responsibilities within the Trust ...................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Assessment of the child ................................................................................................ 7"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "ARV prescribing and dispensing ................................................................................... 8"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Immunisation, monitoring and Follow-up ...................................................................... 9"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Useful numbers........................................................................................................... 10"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "Training requirements ................................................................................................. 11 10 Monitoring and audit ................................................................................................... 11 11 Approval and implementation ..................................................................................... 11 12 Equality impact assessment ....................................................................................... 11 13 References ................................................................................................................. 12 Appendix 1: Assessment proforma .................................................................................... 13 Appendix 2: Process flowchart ........................................................................................... 15 Appendix 3: Immediate action flowchart ............................................................................ 16 Appendix 4: Suggested PEP regimens (CHIVA, 2017) ...................................................... 17 Appendix 5: Preliminary equality analysis .......................................................................... 19"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "Occasionally, Sexual Assault Referral Centre (SARC) will see children aged under 13 who require assessment for Post-Exposure Prophylaxis after Sexual Exposure (PEPSE) following sexual assault/rape. In the past, SARC would seek guidance on this from whomever they could locally find to advise. This process will now be formalised, with the Southend hospital based HIV/paediatric team seeing all children across the MSE and additionally offering advice and ARV dispensing for children seen at the Essex/Hertfordshire SARC."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "Animal studies demonstrate that PEP may reduce risk of HIV transmission. Prospective randomized controlled trials (RCTs) to determine the efficacy of PEPSE have not been performed and are not feasible due to the ethics of withholding a potentially efficacious treatment and the difficulty in recruiting a sufficient sample size. A retrospective case-controlled study among health-care workers occupationally exposed to HIV infection demonstrated that a 28-day course of zidovudine was protective (Cardo et al, 1997)."
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "The risk of community acquired HIV in children is extremely low. However, children and adolescents are potentially at risk of contracting HIV from a variety of exposures, including needlestick injury, sexual abuse and consensual sexual activity in adolescence (Merchant RC and Keshavarz)."
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this document is to:"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Provide guidance on assessing children aged under 13 for HIV PEPSE and offering clinical advice to other care providers outside MSE within the Essex and Hertfordshire area."
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure that consistent, safe and up to date advice and care is given to the children named above and the care providers involved with them post sexual assault."
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This Guideline may also be used for assessing children over the age of 13 years although these children are usually issued PEPSE via sexual health services and do not always need to see a paediatrician. They may also be used for non- sexual intercourse related exposures as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "text": "."
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "type": "table",
            "sequence_num": 29,
            "data": {
                "num_rows": 11,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "ART"
                    },
                    {
                        "text": "Antiretroviral Therapy (HIV medication)"
                    },
                    {
                        "text": "ARV's"
                    },
                    {
                        "text": "Anti-Retroviral's (HIV medication)"
                    },
                    {
                        "text": "Assessor"
                    },
                    {
                        "text": "The HIV Nurse Consultant and/or Paediatric doctor or SARC paediatrician who assesses the child for PEPSE either face to face or over the phone"
                    },
                    {
                        "text": "Child"
                    },
                    {
                        "text": "In this guideline, this will refer to the under 13 year old requiring PEPSE assessment"
                    },
                    {
                        "text": "ED"
                    },
                    {
                        "text": "Emergency Department"
                    },
                    {
                        "text": "HIV"
                    },
                    {
                        "text": "Human Immunodeficiency Virus"
                    },
                    {
                        "text": "Local area"
                    },
                    {
                        "text": "The geographic area served by the MSE Trust"
                    },
                    {
                        "text": "MSE"
                    },
                    {
                        "text": "Mid and South Essex NHS Foundation Trust"
                    },
                    {
                        "text": "PEPSE"
                    },
                    {
                        "text": "Post exposure prophylaxis after sexual exposure"
                    },
                    {
                        "text": "SARC"
                    },
                    {
                        "text": "Sexual Assault Referral Centre"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role and responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "MSE Medicines Assurance Group"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Exception reporting to the MSE Patient Safety & Quality Group on developments, concerns and progress concerning use of PEPSE in children under 13 years"
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "The <13 HIV PEPSE working group"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The <13 HIV PEPSE working group will ensure that this Guideline is kept up to date and accurate. They are responsible for delivering the care detailed in this guideline along with on-call paediatric consultants/registrars."
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The HIV Nurse Consultant will audit the proforma's annually to ensure that the correct process is being followed. She will provide advice and guidance to all parties as required."
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Paediatricians who are specialised in or have an interest in HIV will work with the HIV Nurse Consultant to ensure that the correct care and advice is given."
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "Chief Executive"
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "text": "As the Trust's accountable officer has overall responsibility for ensuring the Trust has robust, complete and up to date documents in place to govern and guide activities so that legal, and national requirements are met."
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Has the overall responsibility for compliance with guidance in HSC 2008/001"
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.4,
                "text": "Clinical Director for Paediatrics"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that the paediatricians are supported to deliver the care described in this guideline."
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that the correct people and room resources are available to deliver the care outlined in this guideline."
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.5,
                "text": "Site Director of Nursing"
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance on site by all professions they oversee and that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.6,
                "text": "Accident Centre Clinical Lead"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Accident Centre will be made aware of this guideline and will be aware that they continue to see children within the MSE out of hours, and refer out of area queries to the on-call paediatrician."
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Continue to liaise with the <13 HIV PEPSE working group to ensure seamless, patient led care is delivered."
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.7,
                "text": "Chief Pharmacist"
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Is accountable to the chief executive for ensuring compliance with this policy and that relevant pharmacy staff are aware of its contents."
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring a monitoring process exists and functions for policy standard."
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Chief Pharmacist delegates this responsibility to the Deputy Chief Pharmacist and site clinical lead pharmacists for delivery."
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.8,
                "text": "Operational Lead Technician"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure that there is a supply of each medication that may be required as PEPSE at all times in the Pharmacy department"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.9,
                "text": "HIV Specialist Pharmacist"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Oversee process of the recourse of funds from other trusts"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Pharmacy staff"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure timely dispensing of prescriptions for PEPSE, treating them as a critical medication."
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure medications are sent via immediate courier"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Assessment of the child"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "All children must be assessed, either in person if within the Trust, or by telephone discussion with the parent and/or relevant clinician if outside the Trust. This must be done in a sensitive manner as to minimise further distress to the child and parents. As much as possible, children should be seen during normal working hours to minimise distress and ensure that appropriate expertise is readily available. Assessment will include the child's demographic details, allergies, relevant medical history and medication history as well as assessment of the sexual assault and the risk of HIV posed to the child. The assessor will decide whether to prescribe ARV's and if so which to prescribe (See appendix 3), taking further advice if necessary. In many cases, the child's initial assessment will be at SARC and the Southend Hospital assessor may need only to arrange ARV prescription and dispensing and appropriate follow up for the child. Please note, SARC are unable to do venous blood sampling."
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "During working hours, SARC will contact the HIV Nurse Consultant on 01702 435555 x6340 to refer the child and she will liaise with the specialist paediatricians and arrange to assess the child. If the child is local, they will be seen in Paediatric ED, if out of area a telephone assessment will be done. Outside of working hours the child will be assessed in Paediatric ED if local and offered PEPSE if appropriate and appropriate blood tests and hepatitis B immunisation. They will then need referring to the HIV Nurse Consultant/paediatric team for follow-up the next working day. For out of area children outside of working hours, the on-call paediatric Registrar should be contacted via switchboard. They will seek further support from a paediatric consultant if required."
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "An assessment proforma (See Appendix 1) must be completed for each child at the time of assessment and each child will have a record created on Medway if they do not already have one (this can be done the following working day). The proforma will be scanned to CED and a copy will be sent to Laura Hilton (HIV Nurse Consultant) for audit purposes. A copy should also be emailed to SARC at essex.paeds@nhs.net  Local children might also have notes made in their medical record."
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "For children assessed who are outside of the Trust, advice will be given and PEP dispensed and couriered if necessary. All follow-up will then fall under the remit of the child's local hospital. Within the Trust, children will be seen at their local hospital if possible to limit inconvenience to them and their caregiver."
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "ARV prescribing and dispensing"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 72.0,
                "text": "The child must be seen as soon as possible for PEPSE assessment. HIV PEP is most effective if started within 1 hour of exposure, but may be beneficial up to  hours after. However, consideration should be made to level of risk and whether the face to face assessment can wait until the next working day. The child's family should be counselled about likely side effects and given contact phone numbers in case of concerns during or after the treatment period. The assessor will also need to consider the child's weight and ability to swallow."
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Children who are able to swallow and are over 35KG with intact renal function should be started on"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Tenofovir 245mg/Emtricitabine 200mg 1 tablet daily"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Raltegravir 1200mg once a day (using 2 x 600mg tablets)"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "This will be provided by SARC or the hospital where the child has been assessed."
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "See Appendix 4 for further information and alternative regimes if the patient falls out of the criteria above."
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.5,
                "text": "See Appendix 3 for immediate action flowchart to inform assessment of risk"
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 28.0,
                "text": "For children within the MSE seen within hours, who require an alternative PEP regime, 28 days PEP will be prescribed and dispensed at Southend Hospital. If possible, the child should be seen at their local hospital with the Southend Paediatric or HIV team advising and Southend hospital pharmacy couriering medication as needed. Standard regime PEP will be dispensed by the assessing hospital or SARC. If they have been seen out of hours in accident centre, 5 or  days may be prescribed and they will be instructed to stop after  days."
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 28.0,
                "text": "For out of area children, a decision will be made by the assessor as to whether the child requires PEPSE and if so, which regime and which formulation. The assessor will then liaise with Southend Hospital pharmacy (on call pharmacist out of hours) to arrange dispensing and couriering the medication to the local hospital where the child is being seen, or SARC, as appropriate. The full  days will be sent."
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.8,
                "text": "During working hours (09.00-17.00 Monday-Friday), prescribing for all children (within or outside of the Trust) will be via WellSky ePMA. Outside of hours, a paper prescription can be written and a copy kept to scan onto CED. The on-call pharmacist will then need to be contacted to dispense the ARV's and arrange delivery. Pharmacy working hours are:"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monday - Friday 09:00 - 18:00 \u2013 01702 435555 x 6655"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monday to Friday 18:00 until next day (evening and overnight) - on call pharmacist via switchboard"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Saturday and Sunday - 08:30 - 16:00 \u2013 01702 435555 x 6655"
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Saturday and Sunday 16:00 until next day - on call pharmacist via switchboard"
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Immunisation, monitoring and follow-up"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.1,
                "text": "HBV For a significant exposure to an unknown source an accelerated course of HBV immunisation (Day 0, 1 month and 2 months) should be offered. The Health Protection Agency recommends the use of intramuscular hepatitis B immunoglobulin only if the source is known to be HBV infected, although would agree to its use with an unknown source if compelling circumstances existed. The Hepatitis B vaccinations can be delivered by either the assessor or the child's GP, dependant on parent preference. If the parent prefers the GP to deliver, a letter must be written to the GP detailing the dosing schedule. The first vaccination should be given by the assessor to ensure rapid initiation."
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.2,
                "text": "HCV There is no recognised PEP for HCV. Families may be counselled that, in the event of HCV seroconversion, therapy is increasingly successful."
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.3,
                "text": "Tetanus The need for tetanus injection/booster should be assessed per usual practice."
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.4,
                "text": "Emergency contraception and screening for sexually transmitted infections SARC will offer emergency contraception and sexual health screening as appropriate. The assessor should ensure that this has happened. Occasionally, it may be more appropriate for the Southend based assessor to undertake the screening in order to streamline care,"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.5,
                "text": "Safeguarding SARC will make safeguarding referrals and other referrals as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.6,
                "text": "Outpatients Visits"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Day 1: Child is assessed in Accident Centre or on Neptune ward and given PEP if appropriate, baseline HIV, Syphilis, Hep B and C bloods taken and accelerated Hepatitis B course started if appropriate."
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 72.0,
                "text": "Within  hours: Review on Neptune ward or by telephone call to parent if already seen face to face to assess adherence and toxicity, decide whether PEP should continue for the full four-week course. Document and give baseline HIV, Syphilis, HBV, HCV Ab results. Arrange psychological support as necessary."
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Newly diagnosed Hepatitis B infection: If the exposed patient is HBsAg positive there is a risk of flare of hepatitis after Tenofovir/Emtricitabine is stopped and specialist advice should be sought prior to the cessation of PEP"
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Day : Review in clinic, assess adherence and toxicity, check FBC, U&E, LFTs."
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 28.0,
                "text": "Day : Review in clinic, assess adherence and toxicity, check FBC, U&E, LFTs (if abnormalities on previous blood tests or clinically indicated). Give 2nd Hepatitis B dose."
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 1,
                "text": "A minimum of 4 weeks AFTER PEP completion (8 weeks from high risk exposure): Follow-up HIV testing should be undertaken with a fourth generation combined HIV antibody/ antigen assay. Antibody screening for Syphilis, Hepatitis B and C is also recommended. Optimally this should be performed 4-8 weeks after completing the 3 doses of HBV vaccine, so that infection can be excluded (HBsAg and HBcAb) and to ascertain that the vaccine response was satisfactory (HBsAb >10mIU/ml). If ongoing risk of exposure to HBV then a 4th dose of HBV vaccine should be given at 12 months. If further HBV vaccination required arrange appropriate follow up (either clinic or GP based)."
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Useful numbers"
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "type": "table",
            "sequence_num": 94,
            "data": {
                "num_rows": 8,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "HIV Nurse Consultant (MSE wide)"
                    },
                    {
                        "text": "01702 435555 x6340"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "07887 654390"
                    },
                    {
                        "text": "Paediatric Registrar (Southend)"
                    },
                    {
                        "text": "01702 385672"
                    },
                    {
                        "text": "Paediatric Associate Specialist (Southend)"
                    },
                    {
                        "text": "01702 435555 x8180"
                    },
                    {
                        "text": "HIV Specialist Pharmacist (Southend)"
                    },
                    {
                        "text": "01702 435555 x6655"
                    },
                    {
                        "text": "Infectious disease Consultant (Southend)"
                    },
                    {
                        "text": "01702 435555 x6956"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "07840 566904"
                    },
                    {
                        "text": "SARC essex.paeds@nhs.net"
                    },
                    {
                        "text": "01277 240620"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Training requirements"
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "No specific training requirements. The PEP decision maker must have HIV and ARV's knowledge and experience."
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Monitoring and audit"
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Outlined  below  is  the  Trust's  process  of  monitoring  compliance  with,  and  the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "type": "table",
            "sequence_num": 99,
            "data": {
                "num_rows": 3,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "PEP prescribed appropriately"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "HIV Nurse Consultant"
                    },
                    {
                        "text": "Annual"
                    },
                    {
                        "text": "<13 PEPSE working party"
                    },
                    {
                        "text": "<13 PEPSE working party"
                    },
                    {
                        "text": "Proforma comleted fully and uploaded to CED in a timely manner"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "HIV nurse Consultant"
                    },
                    {
                        "text": "Annual"
                    },
                    {
                        "text": "<13 PEPSE working party"
                    },
                    {
                        "text": "<13 PEPSE working party"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Approval and implementation"
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.0,
                "text": "All policies, procedures and guidelines will be approved by the under  PEPSE working group and the HIV Clinical Governance group, which are the specialist groups with the authority to approve local paediatric HIV guidelines. Approval will also be sought from the Medication assurance Committee. The guideline will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.0,
                "text": "It is the author's responsibility to inform the under  PEPSE working group of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Equality impact assessment"
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 5)"
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "text": "BHIVA/BAASH (2021) UK Guideline for the use of HIV Post-Exposure Prophylaxis . Following Sexual Exposure (PEPSE) Found at https://www.bashhguidelines.org/media/1269/pep-2021.pdf"
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, et al (1997). A casecontrol study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. The New England journal of medicine.;337(21):1485-90."
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Foster C, Tudor-Williams G, and Bamford A (2017) Post-Exposure Prophylaxis (PEP) Guidelines for children and adolescents potentially exposed to blood-borne viruses. Found at https://www.chiva.org.uk/files/1215/4454/3739/CHIVA_PEP_2017.pdf"
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Merchant RC and Keshavarz R (2001) Human immunodeficiency virus post- exposure prophylaxis for adolescents and children. Pediatrics.; 108(2): 38"
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Assessment proforma"
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "type": "table",
            "sequence_num": 112,
            "data": {
                "num_rows": 13,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Childs Name:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Date of Birth:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Hospital/NHS Number:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "If outside of MSE which hospital is reporting:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Name of reporting Physician:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Date & Time of Incident:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Brief Outline of Incident:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "High Risk/Moderate Risk/ Low Risk/No Risk: (see Appendix 3)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Is PEP Indicated Yes/No:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "If yes to PEP, what is the child's weight and height?"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Allergies:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Medical conditions:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Other medications:"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 113,
            "data": {
                "num_rows": 12,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Tablet swallowing ability:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "PEP regime prescribed:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Address to be couriered to:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "If within Trust: Is Hepatitis B vaccination indicated?:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "1st dose given: (put sticker on proforma)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Follow up plans for child:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Any other information:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Signature of clinician completing the proforma:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Name:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Designation:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Date and Time:"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: Process flowchart"
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "type": "image",
            "sequence_num": 115,
            "data": {
                "url": "MSEGL-21019 Advising on and issuing PEPSE in under 13 year olds guideline 1.0.003.jpeg"
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 3: Immediate action flowchart"
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 1,
                "text": "see BASHH PEPSE guidelines (bashhguidelines.org) p24 for risk assessment"
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "type": "image",
            "sequence_num": 118,
            "data": {
                "url": "MSEGL-21019 Advising on and issuing PEPSE in under 13 year olds guideline 1.0.004.jpeg"
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 4: Suggested PEP regimens (CHIVA, 2017)"
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "type": "table",
            "sequence_num": 120,
            "data": {
                "num_rows": 5,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Age (years)"
                    },
                    {
                        "text": "PEP \u2013 preferred For up to date dosing \u2013 check CHIVA (link below)"
                    },
                    {
                        "text": "PEP \u2013 alternative For up to date dosing \u2013 check CHIVA (link below)"
                    },
                    {
                        "text": "10 +"
                    },
                    {
                        "text": "Raltegravir+ Truvada\u00ae (emtricitabine 200mg/tenofovir disoproxil fumarate (TDF) 245mg) NB if under 35kg, in centres where TDF paediatric formulations are immediately available, we would recommend age and weight appropriate dosing of raltegravir + TDF + lamivudine"
                    },
                    {
                        "text": "Raltegravir + lamivudine 150mg/zidovudine 300mg combined tablet OR Kaletra\u00ae + lamivudine 150mg/zidovudine 300mg combined tablet"
                    },
                    {
                        "text": "6-9"
                    },
                    {
                        "text": "Raltegravir + lamivudine + zidovudine"
                    },
                    {
                        "text": "Kaletra\u00ae + lamivudine+ zidovudine OR Raltegravir or Kaletra\u00ae + paediatric tenofovir + lamivudine"
                    },
                    {
                        "text": "2- <6"
                    },
                    {
                        "text": "Kaletra\u00ae + lamivudine + ziovudine"
                    },
                    {
                        "text": "Raltegravir + lamivudine + zidovudine OR Raltegravir or Kaletra\u00ae + paediatric tenofovir + lamivudine"
                    },
                    {
                        "text": "<2"
                    },
                    {
                        "text": "Kaletra\u00ae + lamivudine + zidovudine"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Notes:"
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 1,
                "text": "For up to date dosing schedules, please visit CHIVA ART dosing table http://www.chiva.org.uk/"
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "type": "image",
            "sequence_num": 123,
            "data": {
                "url": "MSEGL-21019 Advising on and issuing PEPSE in under 13 year olds guideline 1.0.005.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Guideline for advising on and issuing PEPSE in under  year olds / MSEGL-21019 1.0"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Guideline for advising on and issuing PEPSE in under 13 year olds / MSEGL-21019 1.0"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix5: Preliminary equality analysis"
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Guideline for advising on and issuing PEPSE in under 13 year olds (Please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "type": "table",
            "sequence_num": 129,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2612 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 130,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Implement a formal process for assessing under 13 year olds requiring PEPSE and to provide a advise service for other hospitals in Essex and Hertfordshire"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Standardised care for all children requiring this service"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "The children will receive a more streamlined and standardised care pathway and the clinicians involved will have a clear set of Guidelines to work to."
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 and 2. With the<13 PEPSE working group and the HIV clinical governance group"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 131,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Laura Hilton"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "HIV Nurse Consultant"
                    },
                    {
                        "text": "21 April 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 132
        }
    ]
}